샘플 요청 목록

 카트 문의
시장보고서
상품코드
1862208

OoC(Organ On Chip) : 세계 시장 점유율과 순위, 총판매량 및 수요 예측(2025-2031년)

Organ On Chip - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

2024년 세계의 OoC(Organ On Chip) 시장 규모는 1억 6,600만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 30.2%로 확대하며, 2031년까지 10억 7,600만 달러에 달할 것으로 예측됩니다.

OoC(Organ on Chip)는 인체 장기의 기계적, 생물학적 특성을 재현한 소형 장치입니다. 이 칩에는 살아있는 인간 세포로 덮인 미세한 채널이 포함되어 있으며, 조직층을 형성합니다. 심장, 간, 폐, 신장, 장 등 다양한 장기의 생리적 기능을 모방할 수 있으며, 연구자들이 장기 고유의 기능과 질병을 더 깊이 이해할 수 있습니다. 이러한 모델은 일반적으로 마이크로플루이딕스 기술을 사용하여 제조됩니다. 투명한 소형 칩 내에서 인간 세포를 배양하여 장기 고유의 기능을 시뮬레이션하고, 질병 과정이나 약물 반응 등을 조사할 수 있습니다. 보다 정확하고 확장 가능하며 인간과 관련된 데이터를 제공함으로써 인간 OoC(organ-on-a-chip)는 생의학 연구와 약물 시험에 혁명을 가져왔으며, 기존 동물 모델과 인간 임상시험 사이의 가교 역할을 하고 있습니다.

OoC(organ-on-a-chip) 시장은 효율적이고 정확하며 윤리적으로 적합한 체외 생체 모델에 대한 수요 증가가 주요 촉진요인입니다. 기존의 의약품 개발 방식은 비용과 시간이 많이 소요되고, 임상 적용 성공률이 낮은 경향이 있습니다. 이에 반해, 인간 장기의 미세환경과 기능을 충실하게 재현하는 OoC(organ-on-a-chip) 기술은 약물 스크리닝의 효율성과 예측 정확도를 향상시킬 수 있는 유망한 대안을 제시할 것입니다. 특히 북미, 유럽 등 지역에서의 동물실험 규제 강화도 '3R 원칙'(대체, 감소, 개선)에 따른 첨단인 대체 방법의 도입을 가속화하고 있으며, OoC(organ-on-a-chip)는 윤리적으로 바람직한 해결책이 되고 있습니다. 또한 맞춤형 의료, 정밀의료의 부상으로 환자 유래 세포를 이용한 장기칩이 개인별 맞춤 약품 시험 및 반응 예측에 활용되고 있습니다. 재생의료, 면역치료, 바이오엔지니어링의 기술적 진보가 장기칩 시스템의 다양화 및 플랫폼화를 지원하고 있습니다. 또한 생명공학 분야의 민관 양측의 지속적인 투자가 장기칩 플랫폼의 상용화를 촉진하고 있습니다. 다중 장기 칩이 진화하고 AI, 바이오센서, 기타 디지털 헬스 기술과 통합됨에 따라 신약 개발, 독성 테스트, 질병 모델링과 같은 고부가가치 응용 분야에서 시장이 빠르게 성장할 것으로 예측됩니다.

OoC(Organ-on-Chip)의 주요 세계 업체로는 에뮬레이트, 미메타스, 티스유즈 등이 있습니다. 상위 3개사의 점유율은 약 40%를 차지하고 있습니다. 전 세계 OoC(Organ-on-Chip)는 주로 미국과 유럽에서 생산되고 있으며, 두 지역에서 80% 이상의 점유율을 차지하고 있습니다. 북미가 가장 큰 시장으로 약 43%, 유럽과 일본이 각각 37%, 8%의 점유율을 차지하고 있습니다.

이 보고서는 세계 OoC(Organ-on-Chip) 시장에 대해 총매출액, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 최종사용자별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

이 보고서는 2024년을 기준 연도, 2020-2031년의 과거 데이터와 예측 데이터를 바탕으로 OoC(Organ-on-Chip) 시장 규모(매출 및 매출액(백만 달러)를 추정 및 예측했습니다. 정량적, 정성적 분석을 통해 독자들이 비즈니스/성장 전략 수립, 시장 경쟁 구도 평가, 현재 시장에서의 자사 포지셔닝 분석, OoC(Organ-on-Chip)에 대한 정보에 기반한 비즈니스 의사결정을 내리는데 도움을 드리고자 합니다.

시장 세분화

기업별

  • Emulate
  • Mimetas
  • TissUse
  • Valo Health
  • CN Bio Innovations
  • Hesperos
  • Draper Laboratory
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory
  • Altis Biosystems
  • Bi/ond
  • Netri
  • Xona Microfluidics
  • SynVivo, Inc.
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
  • InSphero

유형별 부문

  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • 기타 조직

최종사용자별 부문

  • 제약·바이오테크놀러지 기업
  • 학술·연구기관
  • 화장품 업계
  • 기타

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트
    • 기타 중동 및 아프리카
KSA 25.12.22

자주 묻는 질문

  • 2024년 OoC(Organ-on-Chip) 시장 규모는 어떻게 되나요?
  • OoC(Organ-on-Chip) 기술의 주요 장점은 무엇인가요?
  • OoC(Organ-on-Chip) 시장의 주요 촉진 요인은 무엇인가요?
  • OoC(Organ-on-Chip) 시장에서 주요 기업은 어디인가요?
  • OoC(Organ-on-Chip) 시장의 주요 지역은 어디인가요?

The global market for Organ On Chip was estimated to be worth US$ 166 million in 2024 and is forecast to a readjusted size of US$ 1076 million by 2031 with a CAGR of 30.2% during the forecast period 2025-2031.

A Organ on Chip is a small-scale device that replicates the mechanical and biological properties of human organs. These chips contain tiny channels lined with living human cells that form tissue layers. They can simulate the physiology of various organs, such as the heart, liver, lungs, kidneys, and intestines, allowing researchers to better understand organ-specific functions and diseases. These models are typically made using microfluidic technology, where human cells are cultured in a small, transparent chip, allowing researchers to simulate organ-specific functions and study disease processes, drug responses, and more. By offering more accurate, scalable, and human-relevant data, Human Organs-on-Chips are revolutionizing biomedical research and drug testing, providing a bridge between traditional animal models and human clinical trials.

The organ-on-a-chip market is primarily driven by the growing demand for more efficient, accurate, and ethically compliant in vitro biological models. Traditional drug development methods are often costly, time-consuming, and have low clinical translation success rates. In contrast, organ-on-a-chip technology, which closely mimics the microenvironment and functions of human organs, offers a promising alternative to improve drug screening efficiency and predictive accuracy. Increasing restrictions on animal testing, especially in regions like North America and Europe, are also accelerating the adoption of advanced alternatives that align with the "3Rs" principle-Replacement, Reduction, and Refinement-making organ-on-a-chip an ethically favorable solution. Furthermore, the rise of personalized and precision medicine is driving the use of patient-derived cells in organ chips for individualized drug testing and response prediction. Technological advancements across regenerative medicine, immunotherapy, and bioengineering are supporting the diversification and platformization of organ chip systems. In addition, sustained investment from both the public and private sectors in biotechnology is facilitating the commercialization of organ-on-a-chip platforms. As multi-organ chips evolve and integrate with AI, biosensors, and other digital health technologies, the market is expected to see rapid growth across high-value applications such as drug discovery, toxicity testing, and disease modeling.

Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.

This report aims to provide a comprehensive presentation of the global market for Organ On Chip, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Organ On Chip by region & country, by Type, and by End User.

The Organ On Chip market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ On Chip.

Market Segmentation

By Company

  • Emulate
  • Mimetas
  • TissUse
  • Valo Health
  • CN Bio Innovations
  • Hesperos
  • Draper Laboratory
  • Nortis
  • Micronit Microtechnologies B.V.
  • Kirkstall
  • Cherry Biotech SAS
  • Else Kooi Laboratory
  • Altis Biosystems
  • Bi/ond
  • Netri
  • Xona Microfluidics
  • SynVivo, Inc.
  • Beijing Daxiang Biotech
  • AVATARGET
  • Suzhou Jiyan Biopharmaceutical
  • InSphero

Segment by Type

  • Brain-on-a-chip
  • Liver-on-a-chip
  • Kidney-on-a-chip
  • Lung-on-a-chip
  • Heart-on-a-chip
  • Intestine-on-a-chip
  • Vessel-on-a-chip
  • Other Organs

Segment by End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Cosmetics Industry
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Organ On Chip company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Organ On Chip in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Organ On Chip in country level. It provides sigmate data by Type, and by End User for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Organ On Chip Product Introduction
  • 1.2 Global Organ On Chip Market Size Forecast (2020-2031)
  • 1.3 Organ On Chip Market Trends & Drivers
    • 1.3.1 Organ On Chip Industry Trends
    • 1.3.2 Organ On Chip Market Drivers & Opportunity
    • 1.3.3 Organ On Chip Market Challenges
    • 1.3.4 Organ On Chip Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Organ On Chip Players Revenue Ranking (2024)
  • 2.2 Global Organ On Chip Revenue by Company (2020-2025)
  • 2.3 Key Companies Organ On Chip Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Organ On Chip Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Organ On Chip
  • 2.6 Organ On Chip Market Competitive Analysis
    • 2.6.1 Organ On Chip Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Organ On Chip Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ On Chip as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Brain-on-a-chip
    • 3.1.2 Liver-on-a-chip
    • 3.1.3 Kidney-on-a-chip
    • 3.1.4 Lung-on-a-chip
    • 3.1.5 Heart-on-a-chip
    • 3.1.6 Intestine-on-a-chip
    • 3.1.7 Vessel-on-a-chip
    • 3.1.8 Other Organs
  • 3.2 Global Organ On Chip Sales Value by Type
    • 3.2.1 Global Organ On Chip Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Organ On Chip Sales Value, by Type (2020-2031)
    • 3.2.3 Global Organ On Chip Sales Value, by Type (%) (2020-2031)

4 Segmentation by End User

  • 4.1 Introduction by End User
    • 4.1.1 Pharmaceutical & Biotechnology Companies
    • 4.1.2 Academic & Research Institutes
    • 4.1.3 Cosmetics Industry
    • 4.1.4 Others
  • 4.2 Global Organ On Chip Sales Value by End User
    • 4.2.1 Global Organ On Chip Sales Value by End User (2020 VS 2024 VS 2031)
    • 4.2.2 Global Organ On Chip Sales Value, by End User (2020-2031)
    • 4.2.3 Global Organ On Chip Sales Value, by End User (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Organ On Chip Sales Value by Region
    • 5.1.1 Global Organ On Chip Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Organ On Chip Sales Value by Region (2020-2025)
    • 5.1.3 Global Organ On Chip Sales Value by Region (2026-2031)
    • 5.1.4 Global Organ On Chip Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Organ On Chip Sales Value, 2020-2031
    • 5.2.2 North America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Organ On Chip Sales Value, 2020-2031
    • 5.3.2 Europe Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Organ On Chip Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Organ On Chip Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Organ On Chip Sales Value, 2020-2031
    • 5.5.2 South America Organ On Chip Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Organ On Chip Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Organ On Chip Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Organ On Chip Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Organ On Chip Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Organ On Chip Sales Value, 2020-2031
    • 6.3.2 United States Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Organ On Chip Sales Value, 2020-2031
    • 6.4.2 Europe Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Organ On Chip Sales Value, 2020-2031
    • 6.5.2 China Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Organ On Chip Sales Value, 2020-2031
    • 6.6.2 Japan Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Organ On Chip Sales Value, 2020-2031
    • 6.7.2 South Korea Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Organ On Chip Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Organ On Chip Sales Value by End User, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Organ On Chip Sales Value, 2020-2031
    • 6.9.2 India Organ On Chip Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Organ On Chip Sales Value by End User, 2024 VS 2031

7 Company Profiles

  • 7.1 Emulate
    • 7.1.1 Emulate Profile
    • 7.1.2 Emulate Main Business
    • 7.1.3 Emulate Organ On Chip Products, Services and Solutions
    • 7.1.4 Emulate Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Emulate Recent Developments
  • 7.2 Mimetas
    • 7.2.1 Mimetas Profile
    • 7.2.2 Mimetas Main Business
    • 7.2.3 Mimetas Organ On Chip Products, Services and Solutions
    • 7.2.4 Mimetas Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Mimetas Recent Developments
  • 7.3 TissUse
    • 7.3.1 TissUse Profile
    • 7.3.2 TissUse Main Business
    • 7.3.3 TissUse Organ On Chip Products, Services and Solutions
    • 7.3.4 TissUse Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.3.5 TissUse Recent Developments
  • 7.4 Valo Health
    • 7.4.1 Valo Health Profile
    • 7.4.2 Valo Health Main Business
    • 7.4.3 Valo Health Organ On Chip Products, Services and Solutions
    • 7.4.4 Valo Health Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Valo Health Recent Developments
  • 7.5 CN Bio Innovations
    • 7.5.1 CN Bio Innovations Profile
    • 7.5.2 CN Bio Innovations Main Business
    • 7.5.3 CN Bio Innovations Organ On Chip Products, Services and Solutions
    • 7.5.4 CN Bio Innovations Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.5.5 CN Bio Innovations Recent Developments
  • 7.6 Hesperos
    • 7.6.1 Hesperos Profile
    • 7.6.2 Hesperos Main Business
    • 7.6.3 Hesperos Organ On Chip Products, Services and Solutions
    • 7.6.4 Hesperos Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Hesperos Recent Developments
  • 7.7 Draper Laboratory
    • 7.7.1 Draper Laboratory Profile
    • 7.7.2 Draper Laboratory Main Business
    • 7.7.3 Draper Laboratory Organ On Chip Products, Services and Solutions
    • 7.7.4 Draper Laboratory Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Draper Laboratory Recent Developments
  • 7.8 Nortis
    • 7.8.1 Nortis Profile
    • 7.8.2 Nortis Main Business
    • 7.8.3 Nortis Organ On Chip Products, Services and Solutions
    • 7.8.4 Nortis Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Nortis Recent Developments
  • 7.9 Micronit Microtechnologies B.V.
    • 7.9.1 Micronit Microtechnologies B.V. Profile
    • 7.9.2 Micronit Microtechnologies B.V. Main Business
    • 7.9.3 Micronit Microtechnologies B.V. Organ On Chip Products, Services and Solutions
    • 7.9.4 Micronit Microtechnologies B.V. Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Micronit Microtechnologies B.V. Recent Developments
  • 7.10 Kirkstall
    • 7.10.1 Kirkstall Profile
    • 7.10.2 Kirkstall Main Business
    • 7.10.3 Kirkstall Organ On Chip Products, Services and Solutions
    • 7.10.4 Kirkstall Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Kirkstall Recent Developments
  • 7.11 Cherry Biotech SAS
    • 7.11.1 Cherry Biotech SAS Profile
    • 7.11.2 Cherry Biotech SAS Main Business
    • 7.11.3 Cherry Biotech SAS Organ On Chip Products, Services and Solutions
    • 7.11.4 Cherry Biotech SAS Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Cherry Biotech SAS Recent Developments
  • 7.12 Else Kooi Laboratory
    • 7.12.1 Else Kooi Laboratory Profile
    • 7.12.2 Else Kooi Laboratory Main Business
    • 7.12.3 Else Kooi Laboratory Organ On Chip Products, Services and Solutions
    • 7.12.4 Else Kooi Laboratory Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Else Kooi Laboratory Recent Developments
  • 7.13 Altis Biosystems
    • 7.13.1 Altis Biosystems Profile
    • 7.13.2 Altis Biosystems Main Business
    • 7.13.3 Altis Biosystems Organ On Chip Products, Services and Solutions
    • 7.13.4 Altis Biosystems Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Altis Biosystems Recent Developments
  • 7.14 Bi/ond
    • 7.14.1 Bi/ond Profile
    • 7.14.2 Bi/ond Main Business
    • 7.14.3 Bi/ond Organ On Chip Products, Services and Solutions
    • 7.14.4 Bi/ond Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Bi/ond Recent Developments
  • 7.15 Netri
    • 7.15.1 Netri Profile
    • 7.15.2 Netri Main Business
    • 7.15.3 Netri Organ On Chip Products, Services and Solutions
    • 7.15.4 Netri Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Netri Recent Developments
  • 7.16 Xona Microfluidics
    • 7.16.1 Xona Microfluidics Profile
    • 7.16.2 Xona Microfluidics Main Business
    • 7.16.3 Xona Microfluidics Organ On Chip Products, Services and Solutions
    • 7.16.4 Xona Microfluidics Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Xona Microfluidics Recent Developments
  • 7.17 SynVivo, Inc.
    • 7.17.1 SynVivo, Inc. Profile
    • 7.17.2 SynVivo, Inc. Main Business
    • 7.17.3 SynVivo, Inc. Organ On Chip Products, Services and Solutions
    • 7.17.4 SynVivo, Inc. Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.17.5 SynVivo, Inc. Recent Developments
  • 7.18 Beijing Daxiang Biotech
    • 7.18.1 Beijing Daxiang Biotech Profile
    • 7.18.2 Beijing Daxiang Biotech Main Business
    • 7.18.3 Beijing Daxiang Biotech Organ On Chip Products, Services and Solutions
    • 7.18.4 Beijing Daxiang Biotech Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.18.5 Beijing Daxiang Biotech Recent Developments
  • 7.19 AVATARGET
    • 7.19.1 AVATARGET Profile
    • 7.19.2 AVATARGET Main Business
    • 7.19.3 AVATARGET Organ On Chip Products, Services and Solutions
    • 7.19.4 AVATARGET Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.19.5 AVATARGET Recent Developments
  • 7.20 Suzhou Jiyan Biopharmaceutical
    • 7.20.1 Suzhou Jiyan Biopharmaceutical Profile
    • 7.20.2 Suzhou Jiyan Biopharmaceutical Main Business
    • 7.20.3 Suzhou Jiyan Biopharmaceutical Organ On Chip Products, Services and Solutions
    • 7.20.4 Suzhou Jiyan Biopharmaceutical Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments
  • 7.21 InSphero
    • 7.21.1 InSphero Profile
    • 7.21.2 InSphero Main Business
    • 7.21.3 InSphero Organ On Chip Products, Services and Solutions
    • 7.21.4 InSphero Organ On Chip Revenue (US$ Million) & (2020-2025)
    • 7.21.5 InSphero Recent Developments

8 Industry Chain Analysis

  • 8.1 Organ On Chip Industrial Chain
  • 8.2 Organ On Chip Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Organ On Chip Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Organ On Chip Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제